Preventing Hypoglycemia in seniors with Type 2 Diabetes: The SUGAR Handshake Intervention
Hypoglycemia – dangerously low blood sugar – is a significant concern for older adults with type 2 diabetes. it can lead to falls, cognitive impairment, and even cardiovascular events.Fortunately, a promising intervention called the SUGAR handshake, led by pharmacists, is demonstrating effectiveness in reducing these risks. Here’s a breakdown of the study, its implications, and what it means for your diabetes management.
Understanding the Study Design
Researchers recently completed a pragmatic randomized controlled trial, known as ADAM-ROSE, to assess the impact of the SUGAR handshake on hypoglycemia prevention in elderly patients. The study focused on a complete educational approach.
What is the SUGAR Handshake?
SUGAR is an acronym representing key educational components:
* Signs/symptoms of hypoglycemia
* Understanding the causes of low blood sugar
* Good glycemic control strategies
* Acknowledgment of individual needs and concerns
* Recap/summary of key details
The “handshake” itself is a pharmacist-led, one-on-one educational session, combining verbal communication with a helpful pictogram for visual reinforcement.
Trial Details:
* Randomization: Patients were randomly assigned in a 1:1 ratio to either the SUGAR handshake intervention or their usual care.
* Participant Numbers: Both groups included 106 patients.
* Intervention Timing: Pharmacist interventions occurred at baseline (day 0), 45 days, and 90 days.
* Qualitative Assessment: Researchers conducted interviews with 12 participants – 5 from the intervention group (at day 45, with 3 more at day 90) and 4 from the usual care group – to gain deeper insights into their experiences.
Key clinical Implications & benefits
The results of the ADAM-ROSE trial are encouraging.Here’s what the study revealed:
* improved Medication Management: The SUGAR handshake significantly improved patients’ knowledge of their medications. this, in turn, boosted their motivation to adopt safer habits.
* Reduced Hypoglycemia Risk: Participants receiving the intervention were less likely to experience hypoglycemic events, without a corresponding change in their overall blood sugar control (fasting hyperglycemia). This is a crucial finding.
* Enhanced Adherence: Trust in pharmacists and the involvement of family members and caregivers played a vital role in helping patients stick with the intervention.
* Similar adherence to Monitoring: Both groups demonstrated comparable levels of adherence to measuring fasting blood glucose and logging instances of hypoglycemia.
Though, researchers also identified potential barriers to adherence, including:
* existing health conditions
* Age-related challenges
* General stress levels
Scaling the Intervention: What’s Next?
While the SUGAR handshake shows considerable promise, researchers acknowledge further steps are needed before widespread implementation. These include:
* Cost-Effectiveness Analysis: Determining if the intervention is financially viable on a larger scale.
* Equity Analysis: Ensuring the intervention is accessible and effective for diverse populations.
* Real-World Validation: Assessing its performance in everyday clinical settings, outside of a controlled trial.
Despite these considerations, the findings strongly support the valuable role pharmacists can play in managing hypoglycemia risk within this vulnerable patient population.
Reference:
- Almoni HY, ayre HM, Powell RA, Armani K. The SUGAR handshake intervention to prevent hypoglycaemia in elderly people with type 2 diabetes: process evaluation within a pragmatic randomised controlled trial.BMC Geriatr.2025;25(1):753. doi:10.1186/s12877-025-06361-2
- Almoni HY, Pascual CR, Grassby P, Ahmadi K. Effectiveness of the SUGAR intervention on hypoglycaemia in elderly patients with type 2 diabetes: A pragmatic randomised controlled trial. Res Social Adm Pharm. 2023;19(2):322-331. doi:10.
Keep reading